Gary Firestein, dean and associate vice chancellor of Translational Medicine at the UCSD School of Medicine, right, works with colleague Jean-Marc Waldburger. Firestein says public-private partnerships are important in a time of decreasing federal grant support.

Gary Firestein, dean and associate vice chancellor of Translational Medicine at the UCSD School of Medicine, right, works with colleague Jean-Marc Waldburger. Firestein says public-private partnerships are important in a time of decreasing federal grant support. Photo by Photo courtesy of UC San Diego

In a bid to fast track the discovery and commercialization of promising new drugs, pharmaceutical giant Pfizer Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129